RIC8B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.439170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.189000E-01
Normal-vs-Stage2
6.132400E-02
Normal-vs-Stage3
1.276560E-01
Normal-vs-Stage4
1.735560E-01
Stage1-vs-Stage2
5.098000E-03
Stage1-vs-Stage3
3.151900E-02
Stage1-vs-Stage4
1.982180E-01
Stage2-vs-Stage3
1.884970E-01
Stage2-vs-Stage4
8.430200E-01
Stage3-vs-Stage4
2.883900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.518970E-01
Normal-vs-AfricanAmerican
6.775400E-01
Normal-vs-Asian
2.223900E-02
Caucasian-vs-AfricanAmerican
3.469400E-01
Caucasian-vs-Asian
2.134800E-01
AfricanAmerican-vs-Asian
2.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.784240E-01
Normal-vs-Female
1.214990E-01
Male-vs-Female
6.124000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.360000E-01
Normal-vs-Age(41-60Yrs)
4.533600E-01
Normal-vs-Age(61-80Yrs)
2.998100E-02
Normal-vs-Age(81-100Yrs)
1.632390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.324000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.351770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.492200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.777800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.601800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.684150E-02
Normal-vs-Daily Drinker
2.257200E-01
Normal-vs-Weekly Drinker
1.358030E-02
Normal-vs-Occasional Drinker
1.164160E-01
Normal-vs-Social Drinker
6.639600E-01
Non Drinker-vs-Daily Drinker
6.442400E-01
Non Drinker-vs-Weekly Drinker
6.704000E-01
Non Drinker-vs-Occasional Drinker
3.408400E-01
Non Drinker-vs-Social Drinker
1.592810E-01
Daily Drinker-vs-Weekly Drinker
4.663600E-01
Daily Drinker-vs-Occasional Drinker
8.274600E-01
Daily Drinker-vs-Social Drinker
2.899400E-01
Weekly Drinker-vs-Occasional Drinker
2.537600E-01
Weekly Drinker-vs-Social Drinker
1.181160E-01
Occasional Drinker-vs-Social Drinker
3.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.155600E-01
Normal-vs-Grade 2
9.941900E-02
Normal-vs-Grade 3
8.642000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.216150E-02
Grade 1-vs-Grade 3
2.467700E-02
Grade 1-vs-Grade 4
2.155600E-01
Grade 2-vs-Grade 3
4.617200E-01
Grade 2-vs-Grade 4
9.941900E-02
Grade 3-vs-Grade 4
8.642000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.616100E-02
Normal-vs-NonDiabetic
1.313220E-01
Diabetic-vs-NonDiabetic
4.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.840420E-01
Normal-vs-NoPancreatitis
8.134200E-02
Pancreatitis-vs-NoPancreatitis
1.032830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.955600E-01
Normal-vs-N1
8.111800E-02
N0-vs-N1
4.234000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.379620E-02
Normal-vs-TP53-NonMutant
6.557000E-01
TP53-Mutant-vs-TP53-NonMutant
1.624140E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
